FindTrial
Sign In

LDH and Ferritin levels in Diabetes Mellitus.

A Comparative Study of Inflammatory Markers among Covid Positive Controlled & Uncontrolled Diabetic Patients Retrospective Study.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/03/031970
Enrollment
100
Registered
2021-03-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: E086- Diabetes mellitus due to underlying condition with other specified complications

Interventions

None listed

Sponsors

Self
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Confirmed Covid-19 Positive patients diagnosed by RT PCR with pre-existing Diabetes mellitus.

Exclusion criteria

Exclusion criteria: Patients with history of other co-morbidities like renal diseases, Liver diseases, Hypertension, malignancy, Heart diseases, Arthritis

Design outcomes

Primary

MeasureTime frame
Higher serum LDH, ferritin and lower albumin levels are the crucial factors in diabetes mellitus to assess the severity of COVID 19 infection and as inflammatory markers especially in uncontrolled diabetic patients.Timepoint: Six months—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Sumantara N S

Rajarajeswari medical college and hospital

sumantara90@gmail.com8553653468

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026